Description
Dasatinib is a kinase inhibitor used to treat:
- Adult patients with newly diagnosed Philadelphia chromosome +Ve (Ph+) chronic myeloid leukemia (CML) in chronic phase.
- Adult patients with Ph+ CML who no longer benefit from, or did not tolerate, other therapy, including Gleevec (imatinib mesylate).
- Adult patients with Ph+ ALL (Acute Lymphoblastic Leukemia) who no longer benefit from, or did not tolerate, other therapy.
- Children with Ph+ chronic myeloid leukemia (Ph+ CML) in chronic phase.